Daptomycin‐Resistant, Methicillin‐ResistantStaphylococcus aureusBacteremia | Zendy

Alexandra Mangili | Zendy; Ioana Bica | Zendy; David R. Snydman | Zendy; Davidson H. Hamer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Daptomycin‐Resistant, Methicillin‐ResistantStaphylococcus aureusBacteremia

Author(s) -

Alexandra Mangili,

Ioana Bica,

David R. Snydman,

Davidson H. Hamer

Publication year - 2005

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/428616

Subject(s) - daptomycin , medicine , bacteremia , staphylococcus aureus , methicillin resistant staphylococcus aureus , drug resistance , microbiology and biotechnology , staphylococcal infections , antibiotics , vancomycin , bacteria , biology , genetics

We describe a patient who developed daptomycin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) during an episode of presumed septic thrombophlebitis of the portal vein. Although daptomycin is an alternative agent for treatment of drug-resistant gram-positive bacterial infections, development of resistance during prolonged use may occur with MRSA bacteremia from a persistent focus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research